Search for other papers by Poh Shean Wong in
Google Scholar
PubMed
Search for other papers by Subashini Rajoo in
Google Scholar
PubMed
Search for other papers by Hairuddin Achmad Sankala in
Google Scholar
PubMed
Search for other papers by Mohamed Badrulnizam Long Bidin in
Google Scholar
PubMed
Background The incidence of lung cancer is increasing worldwide, particularly in developing countries. In the Asia-Pacific region, lung cancer is the most commonly diagnosed cancer among men and the second most common cancer among women after
Search for other papers by Jose E Nunez in
Google Scholar
PubMed
Search for other papers by Sylvia Ng in
Google Scholar
PubMed
Search for other papers by Hanbo Chen in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
Search for other papers by Julie Hallet in
Google Scholar
PubMed
Search for other papers by Calvin Law in
Google Scholar
PubMed
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
PRRT were not co-administered, we highlight the favorable tolerability and low incidence of both acute and long-term adverse effects in line with prior published toxicity data for both PRRT and SBRT as an individual treatment. This is comparable to
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
Search for other papers by Krishna Vikneson in
Google Scholar
PubMed
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
Search for other papers by Tariq Haniff in
Google Scholar
PubMed
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by May Thwin in
Google Scholar
PubMed
Search for other papers by Ahmad Aniss in
Google Scholar
PubMed
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Alex Papachristos in
Google Scholar
PubMed
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Mark Sywak in
Google Scholar
PubMed
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Anthony Glover in
Google Scholar
PubMed
Introduction Well-differentiated thyroid cancer (DTC) and papillary thyroid cancer (PTC) incidence has been increasing in comparison to other thyroid cancers ( Davies & Welch 2014 , Davies & Hoang 2021 ). However, most thyroid cancer
St Vincent’s Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia
Garvan Institute of Medical Research, Sydney, Australia
Search for other papers by Anna Stroud in
Google Scholar
PubMed
St Vincent’s Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia
Garvan Institute of Medical Research, Sydney, Australia
Search for other papers by Pearl Dhaliwal in
Google Scholar
PubMed
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Richard J Harvey in
Google Scholar
PubMed
Search for other papers by Raquel Alvarado in
Google Scholar
PubMed
Faculty of Medicine, Notre Dame University, Sydney, Australia
Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, Australia
Search for other papers by Benjamin P Jonker in
Google Scholar
PubMed
St Vincent’s Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia
Faculty of Medicine, Notre Dame University, Sydney, Australia
Search for other papers by Mark J Winder in
Google Scholar
PubMed
Department of Otolaryngology Head and Neck Surgery, University of Alabama Birmingham, Birmingham, Alabama, USA
Search for other papers by Jessica W Grayson in
Google Scholar
PubMed
Garvan Institute of Medical Research, Sydney, Australia
Department of Endocrinology, St Vincent’s Hospital, Sydney, Australia
Search for other papers by Ann McCormack in
Google Scholar
PubMed
( P = 0.02). Postoperative follow-up was 54.6 ± 56.0 months. Baseline characteristics of primary and revision groups were similar, except for a higher incidence of cavernous sinus invasion and endoscopic access among revision surgery candidates (42
Search for other papers by K E Lines in
Google Scholar
PubMed
Search for other papers by M Stevenson in
Google Scholar
PubMed
Search for other papers by R Mihai in
Google Scholar
PubMed
Search for other papers by I V Grigorieva in
Google Scholar
PubMed
Search for other papers by O A Shariq in
Google Scholar
PubMed
Search for other papers by K U Gaynor in
Google Scholar
PubMed
Search for other papers by J Jeyabalan in
Google Scholar
PubMed
Search for other papers by M Javid in
Google Scholar
PubMed
Search for other papers by R V Thakker in
Google Scholar
PubMed
Introduction Primary hyperparathyroidism (PHPT) is a common endocrine condition with an estimated incidence of ~50 per 100,000 in the general population ( Yeh et al. 2013 , Griebeler et al. 2015 ). The vast majority of patients with PHPT
Department of Internal Medicine, The Bulovka University Hospital, Praha, Czech Republic
Search for other papers by Alexander Kreze in
Google Scholar
PubMed
Search for other papers by Matěj Homer in
Google Scholar
PubMed
Search for other papers by Tereza Barešová in
Google Scholar
PubMed
Search for other papers by Kristina Klemperová in
Google Scholar
PubMed
immune-related adverse events (irAEs). The incidence of endocrinopathies during ICI therapy reaches 10% in meta-analysis of 38 studies, which involved a total of 7551 patients under ICIs ( Deligiannis et al. 2021 ). Among the patients on anti-CTLA-4
Siteman Cancer Center, St Louis, Missouri, USA
Search for other papers by Syed Ehsanullah in
Google Scholar
PubMed
Siteman Cancer Center, St Louis, Missouri, USA
Search for other papers by Nikolaos A Trikalinos in
Google Scholar
PubMed
Background Pancreatic neuroendocrine neoplasms (PanNEN) can be challenging to treat, owing to their rarity and heterogeneity. Their incidence and prevalence have increased in the last few decades and so has, thankfully, our understanding of
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Benjamin J Worrall in
Google Scholar
PubMed
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Alexander Papachristos in
Google Scholar
PubMed
Search for other papers by Ahmad Aniss in
Google Scholar
PubMed
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
Search for other papers by Anthony Glover in
Google Scholar
PubMed
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Stan B Sidhu in
Google Scholar
PubMed
Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Search for other papers by Diana Learoyd in
Google Scholar
PubMed
Department of Endocrinology and metabolism, Royal North Shore Hospital, Sydney, Australia Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Search for other papers by Venessa H M Tsang in
Google Scholar
PubMed
Department of Endocrinology and metabolism, Royal North Shore Hospital, Sydney, Australia Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Search for other papers by Matti Gild in
Google Scholar
PubMed
Search for other papers by Bruce G Robinson in
Google Scholar
PubMed
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Mark S Sywak in
Google Scholar
PubMed
.05). The median time-to-first-recurrence was 1.4 years (range: 0.08–4.3). Major complication rate As described in Table 5 , the incidence of major complications did not change significantly between the pre- and post-publication periods ( n = 461
Department of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, Texas, USA
Search for other papers by Ruaa Al-Ward in
Google Scholar
PubMed
Search for other papers by Celeste Zsembery in
Google Scholar
PubMed
Search for other papers by Mouhammed Amir Habra in
Google Scholar
PubMed
diagnostic imaging and the recognition of ACC over the last century, its annual incidence in adult patients has remained relatively stable which is estimated to be around 0.7–2 cases per million people ( Kerkhofs et al. 2013 ). ACC has a bimodal age
Search for other papers by D Mc Donald in
Google Scholar
PubMed
Search for other papers by M Sherlock in
Google Scholar
PubMed
Search for other papers by C J Thompson in
Google Scholar
PubMed
). Although no study has compared the incidence of SIAD in lung cancer by histological type, it is widely accepted that SIAD due to ectopic production of vasopressin is significantly more common in small cell lung cancer than non-small cell ( Cuesta & Thompson